AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 150 filers reported holding AUDENTES THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $3,326,000 | -33.2% | 118,421 | -9.9% | 0.26% | -19.5% |
Q2 2019 | $4,978,000 | -11.4% | 131,495 | -8.7% | 0.32% | -5.0% |
Q1 2019 | $5,620,000 | +58.0% | 144,022 | -13.7% | 0.34% | +96.5% |
Q4 2018 | $3,558,000 | -62.7% | 166,890 | -30.8% | 0.17% | -44.7% |
Q3 2018 | $9,541,000 | +3.6% | 241,000 | 0.0% | 0.31% | +20.4% |
Q2 2018 | $9,209,000 | – | 241,000 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYQUANT CAPITAL SAS | 767,502 | $45,927,000 | 23.65% |
Chicago Capital Management, LLC | 250,401 | $14,984,000 | 12.57% |
Foresite Capital Management III, LLC | 233,067 | $13,947,000 | 7.82% |
Partner Investment Management, L.P. | 17,795 | $1,065,000 | 7.65% |
RAMIUS ADVISORS LLC | 220,784 | $13,212,000 | 5.68% |
Beryl Capital Management LLC | 550,426 | $32,937,000 | 5.31% |
GARDNER LEWIS ASSET MANAGEMENT L P | 647,460 | $38,744,000 | 5.28% |
FNY Investment Advisers, LLC | 278,861 | $16,687,000 | 5.17% |
WHITE SQUARE CAPITAL LLP | 112,500 | $6,732,000 | 4.87% |
Casdin Capital, LLC | 860,000 | $51,462,000 | 4.73% |